Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Reischl

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
La Radiologia Medica|July 2, 2018
Fast non-enhanced abdominal examination protocols in PET/MRI for patients with neuroendocrine tumors (NET): comparison to multiphase contrast-enhanced PET/CTFerdinand Seith, Christina Schraml, Gerald Reischl, et al.
Diagnostics (Basel, Switzerland)|October 25, 2024
Focal Unspecific Bone Uptake on [<sup>18</sup>F]PSMA-1007 PET: Evaluation Analog PROMISE Criteria and Validation via PET/CT Follow-UpJonas-Alexander Benecke, Eduardo Calderón, Gerald Reischl, et al.
Molecular Imaging and Biology|January 7, 2015
Evaluation of the Metabolic Activity of Echinococcus multilocularis in Rodents Using Positron Emission Tomography TracersAnna-Maria Rolle, Peter T Soboslay, Gerald Reischl, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 21, 2007
Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET resultsGerald Reischl, Donna S Dorow, Carleen Cullinane, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 3, 2009
Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PETInga Liepelt, Matthias Reimold, Walter Maetzler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2021
<sup>131</sup>I-GD2-ch14.18 Scintigraphy to Evaluate Option for Radioimmunotherapy in Patients with Advanced TumorsYing Zhang, Juergen Kupferschlaeger, Peter Lang, et al.
Journal of Clinical Medicine|April 30, 2021
[<sup>18</sup>F]fluoro-ethylcholine-PET Plus 4D-CT (FEC-PET-CT): A Break-Through Tool to Localize the "Negative" Parathyroid Adenoma. One Year Follow Up Results Involving 170 PatientsConstantin Smaxwil, Philip Aschoff, Gerald Reischl, et al.
Nuclear Medicine and Biology|October 4, 2016
[<sup>18</sup>F]Fluoro-azomycin-2´-deoxy-β-d-ribofuranoside - A new imaging agent for tumor hypoxia in comparison with [<sup>18</sup>F]FAZAAnna Schweifer, Florian Maier, Walter Ehrlichmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 26, 2016
Comparison of <sup>68</sup>Ga-labelled PSMA-11 and <sup>11</sup>C-choline in the detection of prostate cancer metastases by PET/CTJohannes Schwenck, Hansjoerg Rempp, Gerald Reischl, et al.
Circulation Research|February 16, 2023
Noninvasive Detection of Smooth Muscle Cell-Derived Hot Spots to Study Atherosclerosis by PET/MRI in MiceSusanne Feil, Dimitri Stowbur, Barbara F Schörg, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
La Radiologia Medica|July 2, 2018
Fast non-enhanced abdominal examination protocols in PET/MRI for patients with neuroendocrine tumors (NET): comparison to multiphase contrast-enhanced PET/CTFerdinand Seith, Christina Schraml, Gerald Reischl, et al.
Diagnostics (Basel, Switzerland)|October 25, 2024
Focal Unspecific Bone Uptake on [<sup>18</sup>F]PSMA-1007 PET: Evaluation Analog PROMISE Criteria and Validation via PET/CT Follow-UpJonas-Alexander Benecke, Eduardo Calderón, Gerald Reischl, et al.
Molecular Imaging and Biology|January 7, 2015
Evaluation of the Metabolic Activity of Echinococcus multilocularis in Rodents Using Positron Emission Tomography TracersAnna-Maria Rolle, Peter T Soboslay, Gerald Reischl, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 21, 2007
Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET resultsGerald Reischl, Donna S Dorow, Carleen Cullinane, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 3, 2009
Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PETInga Liepelt, Matthias Reimold, Walter Maetzler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2021
<sup>131</sup>I-GD2-ch14.18 Scintigraphy to Evaluate Option for Radioimmunotherapy in Patients with Advanced TumorsYing Zhang, Juergen Kupferschlaeger, Peter Lang, et al.
Journal of Clinical Medicine|April 30, 2021
[<sup>18</sup>F]fluoro-ethylcholine-PET Plus 4D-CT (FEC-PET-CT): A Break-Through Tool to Localize the "Negative" Parathyroid Adenoma. One Year Follow Up Results Involving 170 PatientsConstantin Smaxwil, Philip Aschoff, Gerald Reischl, et al.
Nuclear Medicine and Biology|October 4, 2016
[<sup>18</sup>F]Fluoro-azomycin-2´-deoxy-β-d-ribofuranoside - A new imaging agent for tumor hypoxia in comparison with [<sup>18</sup>F]FAZAAnna Schweifer, Florian Maier, Walter Ehrlichmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 26, 2016
Comparison of <sup>68</sup>Ga-labelled PSMA-11 and <sup>11</sup>C-choline in the detection of prostate cancer metastases by PET/CTJohannes Schwenck, Hansjoerg Rempp, Gerald Reischl, et al.
Circulation Research|February 16, 2023
Noninvasive Detection of Smooth Muscle Cell-Derived Hot Spots to Study Atherosclerosis by PET/MRI in MiceSusanne Feil, Dimitri Stowbur, Barbara F Schörg, et al.
Pageof 11